Skip to main content
HCPCS Level II/M-Codes/M1391

M1391 HCPCS Level II Code: All patients who were diagnosed with recurrent melanoma during the current performance period

Medicare Coverage & Payment

  • Medicare coverage: Carrier judgment (CMS coverage code C)
  • Payment category: Service not separately priced (pricing indicator 00)
  • BETOS: Z2
  • Effective: January 1, 2025

Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.

Official Registry Overview & Definition

All patients who were diagnosed with recurrent melanoma during the current performance period is a HCPCS Level II code (M1391) for a Medicare-covered supply, service, or procedure. Short description: All pt dx w/ rec mlnm.

Nearest Codes in This Family

Official HCPCS Level II classifications closest to M1391 in its code family, with their registry titles.

  • M1385 — Documentation of patient reasons for patients who were not seen for the second pam survey (e.g., less than four months between baseline pam assessment and follow-up
  • M1386 — Patients with an excisional surgery for melanoma or melanoma in situ in the past 5 years with an initial ajcc staging of 0, i, or ii at the start of the performance period
  • M1387 — Patients who died during the performance period
  • M1388 — Patients with documentation of an exam performed for recurrence of melanoma
  • M1390 — Patients who do not have a documented exam performed for recurrence of melanoma or no documentation within the performance period
  • M1392 — Documentation of patient reasons for no examination, i.e., refusal of examination or lost to follow-up (documentation must include information that the clinician was unable to reach the patient by phone, mail or secure electronic mail - at least one method must be documented)
  • M1393 — Patients who were not diagnosed with recurrent melanoma during the current performance period
  • M1394 — Stages i-iii breast cancer
  • M1395 — Patients receiving an initial chemotherapy regimen with a defined duration with the eligible clinician or group
  • M1396 — Patients on a therapeutic clinical trial